Tigermed Repurchases 3.41 Million A-Shares for RMB 133.44 Million, Lifts Treasury Stock to 23.67 Million

Bulletin Express

06/16

Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed a share buyback executed on 16 June 2026 on the Shenzhen Stock Exchange. The company repurchased 3.41 million A-shares at prices ranging from RMB 38.66 to RMB 39.78 per share, investing a total of RMB 133.44 million. The volume-weighted average repurchase price was approximately RMB 39.12 per share.

Prior to the transaction, Tigermed had 717.65 million issued shares (excluding treasury shares) and 20.26 million treasury shares. Following the buyback, outstanding shares decreased by 0.35 % to 714.23 million, while treasury shares rose to 23.67 million. The total issued share capital remains unchanged at 737.90 million shares.

All repurchased shares are being held as treasury shares; no immediate cancellation plans were disclosed. The company confirmed that the operation complied with the rules of the Shenzhen Stock Exchange and the Hong Kong Stock Exchange’s Main Board requirements.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1122633830"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1122633830\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1122633830?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-16 17:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122633830","market":"hk","top_or_hot":-1,"title":"Tigermed Repurchases 3.41 Million A-Shares for RMB 133.44 Million, Lifts Treasury Stock to 23.67 Million","media":"Bulletin Express","content":"<p>Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed a share buyback executed on 16 June 2026 on the Shenzhen Stock Exchange. The company repurchased 3.41 million A-shares at prices ranging from RMB 38.66 to RMB 39.78 per share, investing a total of RMB 133.44 million. The volume-weighted average repurchase price was approximately RMB 39.12 per share.</p>\n<p>Prior to the transaction, Tigermed had 717.65 million issued shares (excluding treasury shares) and 20.26 million treasury shares. Following the buyback, outstanding shares decreased by 0.35 % to 714.23 million, while treasury shares rose to 23.67 million. The total issued share capital remains unchanged at 737.90 million shares.</p>\n<p>All repurchased shares are being held as treasury shares; no immediate cancellation plans were disclosed. The company confirmed that the operation complied with the rules of the Shenzhen Stock Exchange and the Hong Kong Stock Exchange’s Main Board requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tigermed Repurchases 3.41 Million A-Shares for RMB 133.44 Million, Lifts Treasury Stock to 23.67 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTigermed Repurchases 3.41 Million A-Shares for RMB 133.44 Million, Lifts Treasury Stock to 23.67 Million\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-06-16 17:03</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed a share buyback executed on 16 June 2026 on the Shenzhen Stock Exchange. The company repurchased 3.41 million A-shares at prices ranging from RMB 38.66 to RMB 39.78 per share, investing a total of RMB 133.44 million. The volume-weighted average repurchase price was approximately RMB 39.12 per share.</p>\n<p>Prior to the transaction, Tigermed had 717.65 million issued shares (excluding treasury shares) and 20.26 million treasury shares. Following the buyback, outstanding shares decreased by 0.35 % to 714.23 million, while treasury shares rose to 23.67 million. The total issued share capital remains unchanged at 737.90 million shares.</p>\n<p>All repurchased shares are being held as treasury shares; no immediate cancellation plans were disclosed. The company confirmed that the operation complied with the rules of the Shenzhen Stock Exchange and the Hong Kong Stock Exchange’s Main Board requirements.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03347","symbol_name":"泰格醫藥","start_time":0,"source_url":"","article_id":"1122633830","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122633830","pubTimestamp":1781600583,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed a share buyback executed on 16 June 2026 on the Shenzhen Stock Exchange. The company repurchased 3.41 million A-shares at prices ranging...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03347":"泰格医药"},"translate_title":"泰格医药1.3344亿回购341万股A股库存股升至2367万","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03347":1},"content_text":"Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed a share buyback executed on 16 June 2026 on the Shenzhen Stock Exchange. The company repurchased 3.41 million A-shares at prices ranging from RMB 38.66 to RMB 39.78 per share, investing a total of RMB 133.44 million. The volume-weighted average repurchase price was approximately RMB 39.12 per share.\nPrior to the transaction, Tigermed had 717.65 million issued shares (excluding treasury shares) and 20.26 million treasury shares. Following the buyback, outstanding shares decreased by 0.35 % to 714.23 million, while treasury shares rose to 23.67 million. The total issued share capital remains unchanged at 737.90 million shares.\nAll repurchased shares are being held as treasury shares; no immediate cancellation plans were disclosed. The company confirmed that the operation complied with the rules of the Shenzhen Stock Exchange and the Hong Kong Stock Exchange’s Main Board requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}